Orlance, Inc. | WebDisclosure

Basculer en Français

10965	Companies
240120	Keywords
168884	Articles
129212	Press releases

Home
Companies
Orlance, Inc.

BRIEF

published on 05/16/2024 at 19:05, 2 years 3 months ago

Orlance, Inc. and Product Creation Studio Forge Partnership for MACH-1 System Development

Biotechnology Clinical Trials Orlance Inc Product Creation Studio MACH-1 System
BRIEF

published on 05/16/2024 at 19:05, 2 years 3 months ago

Partenariat Orlance, Inc. et Product Creation Studio Forge pour le développement du système MACH-1

Biotechnologie Essais Cliniques Orlance Inc Studio De Création De Produits Système MACH-1
PRESS RELEASE

published on 05/16/2024 at 19:00, 2 years 3 months ago

Orlance Announces Strategic Collaboration With Product Creation Studio for the Development of the MACH-1 System
Orlance partners with Product Creation Studio to advance the design of the MACH-1 system for Phase 1 clinical trials. The innovative technology aims to revolutionize vaccine delivery

Vaccine Delivery Product Creation Studio MACH-1 System Orlance Phase 1 Clinical Trials

Accesswire

Published on 09/11/2026 at 17:00, 2 hours 33 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours 33 minutes ago

Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 8 minutes ago

Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours 33 minutes ago

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours 3 minutes ago

AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 18:15, 1 hour 17 minutes ago

CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:07, 1 hour 26 minutes ago

Holding(s) in Company
Published on 09/11/2026 at 18:06, 1 hour 26 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 09/11/2026 at 18:00, 1 hour 33 minutes ago

ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 1 hour 33 minutes ago

ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

Les Echos

Published on 09/11/2026 at 07:00, 12 hours 33 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 12 hours 33 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 12 hours 33 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours 33 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE